[
    [
        {
            "time": "2018-03-15",
            "original_text": "More Prison Inmates Get Access to Hepatitis-C Drugs",
            "features": {
                "keywords": [
                    "Prison",
                    "Inmates",
                    "Hepatitis-C",
                    "Drugs"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "More Prison Inmates Get Access to Hepatitis-C Drugs",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "Top 4 Marijuana Stocks to Watch",
            "features": {
                "keywords": [
                    "Marijuana",
                    "Stocks",
                    "Watch"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "cannabis"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Top 4 Marijuana Stocks to Watch",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "Is Big Pharma Using Corporate Tax Savings to Lower Drug Costs?",
            "features": {
                "keywords": [
                    "Big",
                    "Pharma",
                    "Corporate",
                    "Tax",
                    "Savings",
                    "Lower",
                    "Drug",
                    "Costs"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Is Big Pharma Using Corporate Tax Savings to Lower Drug Costs?",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "Zacks Value Investor Highlights: Diageo, Mylan, Sony, AbbVie and Walgreens",
            "features": {
                "keywords": [
                    "Zacks",
                    "Value",
                    "Investor",
                    "Diageo",
                    "Mylan",
                    "Sony",
                    "AbbVie",
                    "Walgreens"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "diversified"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Zacks Value Investor Highlights: Diageo, Mylan, Sony, AbbVie and Walgreens",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "Today’s Research Reports on Trending Tickers: AbbVie Inc. and Amgen Inc.",
            "features": {
                "keywords": [
                    "Research",
                    "Reports",
                    "Trending",
                    "Tickers",
                    "AbbVie",
                    "Amgen"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech",
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Today’s Research Reports on Trending Tickers: AbbVie Inc. and Amgen Inc.",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-15",
            "original_text": "AbbVie Inc (NYSE:ABBV): Time For A Financial Health Check",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Financial",
                    "Health",
                    "Check"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Inc (NYSE:ABBV): Time For A Financial Health Check",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]